Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Cannabis

Page 16
  1. Apr 23, 2026 · 07:01 · OPTI · Routine +

    Optimi Health Files Financing for Nasdaq Listing as Ibogaine Initiative Gains Momentum

    Optimi Health Files LIFE Offering Document in Connection with NASDAQ Listing

    01
  2. Apr 23, 2026 · 07:00 · TLRY · Routine +

    Strategic Pivot to Medical Cannabis and Global Beverage Platform

    BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

    02
  3. Apr 23, 2026 · 07:00 · GTII · Routine +

    Green Thumb Doubles Down on Buybacks as Cash Pile Grows

    Green Thumb Industries Announces an Additional $100 Million Authorized for its Share Repurchase Program

    03
  4. Apr 23, 2026 · 06:00 · HITI · Neutral

    High Tide Probes Market Manipulation as Earnings Beat Fails to Lift Shares

    High Tide Announces Proactive Steps to Investigate and Address Potential Manipulation of Its Common Shares

    04
  5. Apr 22, 2026 · 17:45 · DHB · Routine +

    Delivra Secures Manufacturing Partner Amidst Revenue Decline and EBITDA Widenings

    Delivra Health Brands Enters into Licence Agreement with Peak Processing to Manufacture and Distribute Its Topical Brand LivRelief Infused(TM)

    05
  6. Apr 22, 2026 · 08:00 · AAWH · Routine +

    Ascend Wellness Expands NJ Footprint Amid Revenue Decline and Debt Burden

    Ascend Wellness Holdings Announces the Opening of East Coasting Dispensary in Eatontown, New Jersey

    06
  7. Apr 21, 2026 · 16:05 · MDMA · Routine +

    PharmAla Biotech Gains on Regulatory Tailwinds as Earnings Confirm Growth Amidst Management Shake-Up

    PharmAla Issues Q2 Financial Statements and Grants Options

    07
  8. Apr 21, 2026 · 07:00 · TRIP · Routine +

    Red Light Holland Eyes Pharma Pivot as Psychedelic Policy Shifts

    Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

    08
  9. Apr 21, 2026 · 03:02 · HERB · Routine +

    Liquidity Upgrade Confirms OTCQB Momentum But Execution Risks Remain

    Herbal Dispatch Announces Receipt of U.S. DTC Eligibility and Engagement of Market Maker

    09
  10. Apr 20, 2026 · 09:56 · TLRY · Routine +

    Tilray Brands Reaffirms Global Cannabis Leadership Amidst Post-Rescheduling Consolidation

    Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

    10
  11. Apr 20, 2026 · 09:01 · OILS · Routine +

    Nextleaf Solutions Confirms Capex-Light Expansion Strategy with New Micro-Processing Licence

    Nextleaf Advances Capex-Light Model with New Micro-Processing Site Licence, Supporting Revenue Growth and Margin Expansion

    11
  12. Apr 20, 2026 · 09:00 · AVCN · Neutral

    Avicanna Earnings Mask Revenue Stagnation as Stock Tests Support Levels

    Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics

    12
  13. Apr 20, 2026 · 08:31 · NUMI · Routine +

    Numinus Wellness Positions for Psychedelic Boom Amidst Regulatory Survival Risks

    Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

    13
  14. Apr 20, 2026 · 08:30 · BMND · Material +

    Biomind Labs Claims 100% Remission in Alzheimer's Depression Trial Amidst Regulatory Tailwinds

    Biomind Labs Applauds Landmark Executive Order Accelerating Psychedelic Research and Access in The United States

    14
← Newer Older →